Revisiting the Roco G-protein cycle

Biochemical Journal

Volumn 465, Issue , 2015, Pages 139-147

  Terheyden, Susanne ^a,b   Ho, Franz Y ^a   Gilsba, Bernd K ^a,b   Wittinghofer, Alfred ^a   Kortholt, Arjan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Dimerization; GAD; Guanosine 5 triphosphatase (gtpase); Leucine rich repeat kinase 2 (lrrk2); Parkinson's disease

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; LEUCINE RICH REPEAT KINASE 2; NUCLEOTIDE; ROCO PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; GUANOSINE DIPHOSPHATE; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; ENZYME ACTIVITY; IMMUNOPRECIPITATION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; CHEMICAL STRUCTURE; CHEMISTRY; GEL CHROMATOGRAPHY; HEK293 CELL LINE; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

BACTERIA (MICROORGANISMS);

BACTERIAL PROTEINS; CHROMATOGRAPHY, GEL; CRYSTALLOGRAPHY, X-RAY; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; GUANOSINE DIPHOSPHATE; HEK293 CELLS; HUMANS; MODELS, MOLECULAR; NUCLEOTIDES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES;

EID: 84918508656     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20141095     Document Type: Article

References (31)

1. Lees, A. J., Hardy, J. and Revesz, T. (2009) Parkinson's disease. Lancet 373, 2055-2066 CrossRef PubMed
2. Paisán-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der, B. M., López de Munain, A., Aparicio, S., Gil, A. M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600 CrossRef PubMed
3. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607 CrossRef PubMed
4. Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P. et al. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365, 415-416 PubMed
5. Bosgraaf, L. and van Haastert, P. J. (2003) Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 1643, 5-10 CrossRef PubMed
6. Cookson, M. R. and Bandmann, O. (2010) Parkinson's disease: insights from pathways. Hum. Mol. Genet. 19, R21-R27 CrossRef PubMed
7. Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J. et al. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23, 329-341 CrossRef PubMed
8. Luzón-Toro, B., Rubio, d.l.T., Delgado, A., Pérez-Tur, J. and Hilfiker, S. (2007) Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Hum. Mol. Genet. 16, 2031-2039 CrossRef PubMed
9. West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L. and Dawson, T. M. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. U.S.A. 102, 16842-16847 CrossRef PubMed
10. Cohen, P. and Alessi, D. R. (2013) Kinase drug discovery: what's next in the field? ACS Chem. Biol. 8, 96-104 CrossRef PubMed
11. Deng, J., Lewis, P. A., Greggio, E., Sluch, E., Beilina, A. and Cookson, M. R. (2008) Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc. Natl. Acad. Sci. U.S.A. 105, 1499-1504 CrossRef PubMed
12. Gotthardt, K., Weyand, M., Kortholt, A., van Haastert, P. J. and Wittinghofer, A. (2008) Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J. 27, 2239-2249 CrossRef PubMed
13. Liao, J., Wu, C. X., Burlak, C., Zhang, S., Sahm, H., Wang, M., Zhang, Z. Y., Vogel, K. W., Federici, M., Riddle, S. M. et al. (2014) Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain. Proc. Natl. Acad. Sci. U.S.A. 111, 4055-4060 CrossRef PubMed
14. Guo, L., Gandhi, P. N., Wang, W., Petersen, R. B., Wilson-Delfosse, A. L. and Chen, S. G. (2007) The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res. 313, 3658-3670 CrossRef PubMed
15. Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T. and Iwatsubo, T. (2007) GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 46, 1380-1388 CrossRef PubMed
16. Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A. and Cookson, M. R. (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun. 357, 668-671 CrossRef PubMed
17. Li, X., Tan, Y. C., Poulose, S., Olanow, C. W., Huang, X. Y. and Yue, Z. (2007) Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J. Neurochem. 103, 238-247 CrossRef PubMed
18. West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K. L., Dawson, V. L. and Dawson, T. M. (2007) Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223-232 CrossRef PubMed
19. Jordan, M., Schallhorn, A. and Wurm, F. M. (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24, 596-601 CrossRef PubMed
20. Gilsbach, B. K., Ho, F. Y., Vetter, I. R., van Haastert, P. J., Wittinghofer, A. and Kortholt, A. (2012) Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations. Proc. Natl. Acad. Sci. U.S.A. 109, 10322-10327 CrossRef PubMed
21. Vetter, I. R. and Wittinghofer, A. (2001) The guanine nucleotide-binding switch in three dimensions. Science 294, 1299-1304 CrossRef PubMed
22. Liu, M., Dobson, B., Glicksman, M. A., Yue, Z. and Stein, R. L. (2010) Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2, characterization of the kinase and GTPase activities. Biochemistry 49, 2008-2017 CrossRef PubMed
23. Bourne, H. R., Sanders, D. A. and Mccormick, F. (1991) The GTPase superfamily: conserved structure and molecular mechanism. Nature 349, 117-127 CrossRef PubMed
24. Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J. M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A. et al. (2008) The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem. 283, 16906-16914 CrossRef PubMed
25. Sen, S., Webber, P. J. and West, A. B. (2009) Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J. Biol. Chem. 284, 36346-36356 CrossRef PubMed
26. Häbig, K., Gellhaar, S., Heim, B., Djuric, V., Giesert, F., Wurst, W., Walter, C., Hentrich, T., Riess, O. and Bonin, M. (2013) LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and tropomyosin 4. Biochim. Biophys. Acta 1832, 2352-2367 CrossRef PubMed
27. Haebig, K., Gloeckner, C. J., Miralles, M. G., Gillardon, F., Schulte, C., Riess, O., Ueffing, M., Biskup, S. and Bonin, M. (2010) ARHGEF7 (innodatabeta -PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2. PLoS ONE 5, e13762 CrossRef PubMed
28. Xiong, Y., Yuan, C., Chen, R., Dawson, T. M. and Dawson, V. L. (2012) ArfGAP1 is a GTPase activating protein for LRRK2, reciprocal regulation of ArfGAP1 by LRRK2. J. Neurosci. 32, 3877-3886 CrossRef PubMed
29. Civiero, L., Vancraenenbroeck, R., Belluzzi, E., Beilina, A., Lobbestael, E., Reyniers, L., Gao, F., Micetic, I., De Maeyer, M., Bubacco, L. et al. (2012) Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS ONE 7, e43472 CrossRef PubMed
30. James, N. G., Digman, M. A., Gratton, E., Barylko, B., Ding, X., Albanesi, J. P., Goldberg, M. S. and Jameson, D. M. (2012) Number and brightness analysis of LRRK2 oligomerization in live cells. Biophys. J. 102, L41-L43 CrossRef PubMed
31. Gasper, R., Meyer, S., Gotthardt, K., Sirajuddin, M. and Wittinghofer, A. (2009) It takes two to tango: regulation of G proteins by dimerization. Nat. Rev. Mol. Cell Biol. 10, 423-429 CrossRef PubMed